BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Russell MW, Jerse AE, Gray-Owen SD. Progress Toward a Gonococcal Vaccine: The Way Forward. Front Immunol 2019;10:2417. [PMID: 31681305 DOI: 10.3389/fimmu.2019.02417] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Huang J, Zhang Q, Chen J, Zhang T, Chen Z, Chen Z, Yang J, Wang Y, Min Z, Huang M, Min X. Neisseria gonorrhoeae NGO2105 Is an Autotransporter Protein Involved in Adhesion to Human Cervical Epithelial Cells and in vivo Colonization. Front Microbiol 2020;11:1395. [PMID: 32670242 DOI: 10.3389/fmicb.2020.01395] [Reference Citation Analysis]
2 Harrison OB, Maiden MC. Recent advances in understanding and combatting Neisseria gonorrhoeae: a genomic perspective. Fac Rev 2021;10:65. [PMID: 34557869 DOI: 10.12703/r/10-65] [Reference Citation Analysis]
3 Criss AK, Genco CA, Gray-Owen SD, Jerse AE, Seifert HS. Challenges and Controversies Concerning Neisseria gonorrhoeae-Neutrophil Interactions in Pathogenesis. mBio 2021;12:e0072121. [PMID: 34060328 DOI: 10.1128/mBio.00721-21] [Reference Citation Analysis]
4 Maina A, Mureithi M, Kiiru J, Revathi G. Systemic and Mucosal Concentrations of Nine Cytokines Among Individuals with Neisseria gonorrhoeae infection in Nairobi Kenya. AAS Open Res 2022;5:12. [DOI: 10.12688/aasopenres.13351.1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 VanBenschoten HM, Woodrow KA. Vaginal delivery of vaccines. Adv Drug Deliv Rev 2021;178:113956. [PMID: 34481031 DOI: 10.1016/j.addr.2021.113956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Haese EC, Thai VC, Kahler CM. Vaccine Candidates for the Control and Prevention of the Sexually Transmitted Disease Gonorrhea. Vaccines (Basel) 2021;9:804. [PMID: 34358218 DOI: 10.3390/vaccines9070804] [Reference Citation Analysis]
7 Gottlieb SL, Ndowa F, Hook EW 3rd, Deal C, Bachmann L, Abu-Raddad L, Chen XS, Jerse A, Low N, MacLennan CA, Petousis-Harris H, Seib KL, Unemo M, Vincent L, Giersing BK; Gonococcal Vaccine PPC Expert Advisory Group. Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019. Vaccine 2020;38:4362-73. [PMID: 32359875 DOI: 10.1016/j.vaccine.2020.02.073] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
8 Norris Turner A, Carter A, Tzeng YL, Stephens DS, Brown M, Snyder B, Retchless AC, Wang X, Bazan JA. Infection with the US Neisseria meningitidis urethritis clade does not lower future risk of urethral gonorrhea. Clin Infect Dis 2021:ciab824. [PMID: 34543381 DOI: 10.1093/cid/ciab824] [Reference Citation Analysis]
9 Christodoulides M, Humbert MV, Heckels JE. The potential utility of liposomes for Neisseria vaccines. Expert Rev Vaccines 2021;20:1235-56. [PMID: 34524062 DOI: 10.1080/14760584.2021.1981865] [Reference Citation Analysis]
10 Costa-Lourenço APR, Su X, Le W, Yang Z, Patts GJ, Massari P, Genco CA. Epidemiological and Clinical Observations of Gonococcal Infections in Women and Prevention Strategies. Vaccines (Basel) 2021;9:327. [PMID: 33915835 DOI: 10.3390/vaccines9040327] [Reference Citation Analysis]
11 Tien V, Punjabi C, Holubar MK. Antimicrobial resistance in sexually transmitted infections. J Travel Med 2020;27:taz101. [PMID: 31840758 DOI: 10.1093/jtm/taz101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
12 Maurakis SA, Cornelissen CN. Recent Progress Towards a Gonococcal Vaccine. Front Cell Infect Microbiol 2022;12:881392. [DOI: 10.3389/fcimb.2022.881392] [Reference Citation Analysis]
13 Leduc I, Connolly KL, Begum A, Underwood K, Darnell S, Shafer WM, Balthazar JT, Macintyre AN, Sempowski GD, Duncan JA, Little MB, Rahman N, Garges EC, Jerse AE. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae. PLoS Pathog 2020;16:e1008602. [PMID: 33290434 DOI: 10.1371/journal.ppat.1008602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
14 Sánchez-Busó L, Yeats CA, Taylor B, Goater RJ, Underwood A, Abudahab K, Argimón S, Ma KC, Mortimer TD, Golparian D, Cole MJ, Grad YH, Martin I, Raphael BH, Shafer WM, Town K, Wi T, Harris SR, Unemo M, Aanensen DM. A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch. Genome Med 2021;13:61. [PMID: 33875000 DOI: 10.1186/s13073-021-00858-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
15 Russell MW. Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease. J Infect Dis 2021;224:S96-S102. [PMID: 34396399 DOI: 10.1093/infdis/jiaa766] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Abisoye-Ogunniyan A, Carrano IM, Weilhammer DR, Gilmore SF, Fischer NO, Pal S, de la Maza LM, Coleman MA, Rasley A. A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections. Front Pharmacol 2021;12:768461. [PMID: 34899322 DOI: 10.3389/fphar.2021.768461] [Reference Citation Analysis]
17 Jefferson A, Smith A, Fasinu PS, Thompson DK. Sexually Transmitted Neisseria gonorrhoeae Infections-Update on Drug Treatment and Vaccine Development. Medicines (Basel) 2021;8:11. [PMID: 33562607 DOI: 10.3390/medicines8020011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Plotnikoff KM, Donken R, Smith L, Cameron C, LaMontagne DS, Bettinger JA, Sadarangani M, Grennan T, Racey CS, Hybiske K, Naus M, Monteiro A, Ogilvie GS. Priorities for sexually transmitted infection vaccine research and development: Results from a survey of global leaders and representatives. Vaccine X 2021;8:100107. [PMID: 34401741 DOI: 10.1016/j.jvacx.2021.100107] [Reference Citation Analysis]